ESTRO 31 will start with a series of pre-meeting workshops which will be followed by an opening ceremony in the evening.
At ESTRO 31 annual meeting the most up-to-date evidence in clinical, physics, radiobiology and oncology science and technology will be presented, and a broad portfolio of educational opportunities will be provided. Life in the ESTRO house will also be enlightened by special interdisciplinary sessions in a devoted room which will jointly address relevant topics for radiation oncologists, physicists, radiobiologists and RTTs in the same forum, allowing each discipline to enrich their knowledge base.
Symposia and debates are foreseen on new evidences - for the more common tumors and for the challenging unusual clinical presentations - as well as in biology, imaging, physics and technology. This includes the integration of molecular and genetic prediction of tumour and normal tissue response, the combination of radiation therapy with new and more efficient molecular targeted drugs, a more extensive use of particle therapies to better spare normal tissues, a complete integration of 4D image guided treatments, the development of adaptive radiation therapy to the most active part of the tumours as defined by functional imaging and the curative use of stereotactic radiotherapy. All these advances challenge machine and patient specific QA and dosimetry as well as the training and practice of radiation technologists.
All of the leading exhibitors will contribute to ESTRO 31, Europe’s largest industrial exhibition in radiation oncology, offering the opportunity to view the latest products and services in cancer treatment and cancer care.
Please do not hesitate to contact us should you require any further information.
ESTRO 31 Conference Secretariat